HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-02-10
著者
-
Shimizu Keiji
Department Of Neurosurgery Kochi Medical School
-
Nakabayashi Hiromichi
Department Of Neurosurgery Kochi Medical School Kochi University
関連論文
- Preoperative Surgical Approach Planning for Metastatic Pituitary Stalk Tumor Using Multimodal Fusion Imaging in a Neuronavigation System : Case Report
- Usefulness of a Mouse Myelin Basic Protein Promoter for Gene Therapy of Malignant Glioma: Myelin Basic Protein Promoter Is Strongly Active in Human Malignant Glioma Cells
- Infectious Retrovirus Is Inactivated by Serum but Not by Cerebrospinal Fluid or Fluid from Tumor Bed in Patients with Malignant Glioma
- A Simplified General Method for Determination of Recombinant Retrovirus Titers
- Murine Model of Leptomeningeal Dissemination Using Human Medulloblastoma Cells
- STA-MCA Anastomosis and Collateral Circulation
- Rathke's Cleft Cyst with Short-Term Size Changes in Response to Glucocorticoid Replacement
- Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils
- Simultaneous Bilateral Thalamic Hemorrhage:Case Report
- Meningioma Assiciated with Acute Subdural Hematoma-Case Report
- Choroid Plexus Metastasis from Gastric Cancer : Case Report
- HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways
- A Modified Combined Transseptal/Transnasal Binostril Approach for Pituitary Lesions in Patients with a Narrow Nasal Space: Technical Note